[go: up one dir, main page]

Urbanek, 2002 - Google Patents

Mechanisms and manipulations of autoimmune disease in the NOD mouse

Urbanek, 2002

Document ID
5167205735007703458
Author
Urbanek I
Publication year

External Links

Snippet

Human insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease characterized by immune-mediated destruction of the pancreatic islets of Langerhans. The non-obese diabetic (NOD) mouse demonstrates many of the pathological features of human …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Ito et al. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway
ES2112838T5 (en) PEPTIDES RECEIVING T-CELLS AS THERAPEUTIC AGENTS FOR AUTOIMMUNITY AND MALIGNAL DISEASES.
Wen et al. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model
Shi et al. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor α chain
CA2247071C (en) Dna vaccination for induction of suppressive t cell response
US6759239B2 (en) Methods for generating tolerogenic antigen presenting cells
Creusot et al. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice
JPH11196871A (en) Anti-T cell receptor determinants as treatment of autoimmune diseases
JP2001097886A (en) Administration of vaccine to disease caused by pathological response by specific t-cell subpopulation, and method therefor
CA2110055C (en) T cell receptor peptides as therapeutics for immune-related disease
Vandenbark et al. T cell receptor peptides in treatment of autoimmune disease: rationale and potential
Chen et al. Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
Benacerraf Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985
Petzold et al. Dendritic cell-targeted pancreatic β-cell antigen leads to conversion of self-reactive CD4+ T cells into regulatory T cells and promotes immunotolerance in NOD mice
Wilder et al. Genetic factors regulating experimental arthritis in mice and rats
Gorczynski Role of cytokines in allograft rejection
US7378089B2 (en) Gene therapy for the prevention of autoimmune disease
Popov et al. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia
Serre et al. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo
Urbanek Mechanisms and manipulations of autoimmune disease in the NOD mouse
WO2009132283A2 (en) Method for treating autoimmune disorders
Conti-Fine et al. Immunopathogenesis of myasthenia gravis
Cohen-Kaminsky et al. Prospects for a T-cell receptor vaccination against myasthenia gravis
Kong Experimental models for autoimmune thyroid disease: recent developments
Zhong et al. Human growth hormone presented by K14hGH‐transgenic skin grafts induces a strong immune response but no graft rejection